What Are Moderna's Risks?

Keith Speights, The Motley Fool
·3-min read

Moderna (NASDAQ: MRNA) is a high-flying biotech stock with a big year ahead of it. The company should make billions of dollars in 2021 from sales of its COVID-19 vaccine mRNA-1273. In this Motley Fool Live video recorded on Jan.